冷冻你的卵子,解放你的事业":香港公司为员工提供 28 万港元的婴儿奖励 || ‘Freeze your eggs, free your career’: Hong Kong firm offers staff HK$280,000 baby incentive

AI Summary:

---------------

香港一家生物制药公司为每位员工提供 28 万港元(35,850 美元)的补贴,鼓励他们在事业发展的同时成家立业,以帮助提高香港的出生率。

默克香港和澳门公司总经理郑世龙周五表示,员工通常面临着职业发展黄金期和成家立业黄金期的重叠。

"冻结你的卵子,解放你的事业,"程说。"这就是为什么我们希望通过这一举措,给予员工足够的自由和经济支持,让他们既能成家立业,又能一举成名。

这些补贴是默克集团、非政府组织初级保健教育基金会和 Bowtie 人寿保险公司发起的 "家庭事务倡议 "的一部分。

"三家机构在一份联合声明中说:"在鼓励香港优质营商环境的同时,私营企业也应承担部分社会责任,鼓励员工组织家庭,为香港的长远发展做出贡献。

雇员接受试管受精、冷冻卵子、促排卵和不孕症治疗,最高可报销 28 万港元。男性员工也有资格获得相应的治疗费用。

"Cheng 补充说:"默克公司的所有员工在入职的第二天就能获得这项补贴。

三家机构在今年年初对 200 名员工进行了一项关于家庭支持需求的调查,发现经济负担是阻碍香港人生育的主要因素。

近 80% 的受访者认为,抚养一个孩子到 22 岁至少需要 600 万港元。

调查还发现,67%的受访者表示家庭收入超过 10 万港元就足以支付育儿开支。

截至 2023 年底,香港的出生率是全球最低的,在过去四年中下降了 40%,婴儿出生人数从 2019 年的 5.29 万降至 2022 年的 3.25 万。

为了提高出生率,政府在李家超的 2023 年施政报告中宣布向每名新生儿发放 2 万港元的一次性现金奖励。

自该政策于 10 月份推出以来,当局已批准了 16,000 多份 20,000 港元的派款申请。

2024 年初,人口也增长了 0.4%,略高于 750 万,这是继 Covid-19 危机之后连续第二年增长。
---------------

A Hong Kong biopharmaceutical company has offered a subsidy of HK$280,000 (US$35,850) to each of its employees to encourage them to start families while advancing their careers at the same time, in a bid to help boost the city’s birth rate.

Tony Cheng Sai-lung, the managing director of Merck Hong Kong & Macau, said on Friday that employees usually faced an overlap between the prime periods for career advancement and starting families.

“Freeze your eggs and free your career,” Cheng said. “That’s why throughout this initiative, we hope to give employees enough freedom and financial support to start their family yet advance their career all at once.”

The subsidies were part of the “Family Matters Initiative” launched by the Merck Group, NGO Primary Care Education Foundation and Bowtie Life Insurance Company.

“While encouraging the quality business environment of Hong Kong, private enterprises should also shoulder part of their social responsibility by encouraging their staff to organise their families and contribute to the long-term development of Hong Kong,” a joint statement by the three institutions said.

Employees could be reimbursed up to HK$280,000 for treatments such as in vitro fertilisation, egg freezing, ovulation induction and infertility treatment. Male employees would also be eligible for money to reimburse them for applicable treatments.

“All employees at Merck will be able to receive this subsidy as soon as their second day of their onboarding,” Cheng added.

The three organisations conducted a survey on family support needs early this year involving 200 employees and found that financial burden was the primary factor deterring Hongkongers from having children.

Nearly 80 per cent of the respondents believed that at least HK$6 million would be required to raise a child up to the age of 22.

The survey also found 67 per cent of respondents said a family income of more than HK$100,000 would be sufficient to meet childcare expenses.

Hong Kong had the lowest birth rate in the world as of late 2023, declining by 40 per cent over the last four years, with the number of babies born dropping to 32,500 in 2022 from 52,900 in 2019.

In an effort to boost the birth rate, the government announced a one-off cash bonus of HK$20,000 for each newborn in John Lee Ka-chiu’s 2023 policy address.

Authorities have already approved more than 16,000 applications for the HK$20,000 handouts since the policy rolled out in October.

In early 2024, the population also rose 0.4 per cent to just over 7.5 million, growing for the second year in a row following the Covid-19 crisis.

via News - South China Morning Post (author: Alice Kong)
 
 
Back to Top